You are here: Industry Insights > Alzheimer’s disease

News List

Selonterra publishes novel proprietary mechanism for APOE4 in Alzheimer’s disease pharmaasia
February 14, 2017
A single nucleotide change in the DNA variant APOE4 can regulate factors influencing Alzheimer’s disease.
Q&A on strategies for earlier diagnosis of Alzheimer’s disease – MOPEAD lilly
February 14, 2017
Defining strategies to overcome obstacles to early diagnosis and treatment in Alzheimer’s disease: MOPEAD
New study finds benzodiazepines use increases stroke risk in people with Alzheimer’s disease pharmaceutical-technology
January 18, 2017
A new study from the University of Eastern Finland has found the use of drugs such as benzodiazepine and benzodiazepine-like drugs was related to a 20% increased risk of stroke in patients with Alzheimer’s disease.
Selonterra Publishes Novel Proprietary Mechanism for APOE4 in Alzheimer’s Disease b3cnewswire
January 18, 2017
Selonterra LLC announced the publication of the article “Identification of a Nuclear Respiratory Factor 1 Recognition Motif in the Apolipoprotein E Variant APOE4 linked to Alzheimer’s Disease” in Scientific Reports.
New study finds antidepressant use increases hip fracture risk in people with Alzheimer’s disease pharmaceutical-technology
January 13, 2017
A new study from the University of Eastern Finland has found that the use of antidepressants nearly doubles the risk of hip fracture among community-dwelling people with Alzheimer’s disease.

Previous page 1 2 3 Next page